Baseline Characteristics of Children in the International PANS Registry (IPR) Epidemiology Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Jan 24

PMID 38267248

Authors

Erin E Masterson

Jessica M Gavin

Affiliations

Soon will be listed here.

Abstract

Purpose: The International PANS Registry (IPR) Epidemiology Study is a registry-based, longitudinal study. We designed this study to improve phenotyping and characterisation of children with paediatric acute-onset neuropsychiatric syndrome (PANS) and PANS-like features and facilitate multidisciplinary and translational health research. This cohort provides new opportunities to address unresolved research questions related to the broad spectrum of heterogenous PANS-like conditions.

Participants: Inclusion in the IPR Epidemiology Study remains open indefinitely via IPR enrolment online. Participants include children with PANS or who have PANS-like features and their healthy siblings. We collected cross-sectional survey data based on parent report, including details on phenotypic traits and characteristics that, to our knowledge, have not been previously collected for this patient population. We describe the baseline characteristics of cases and their healthy siblings here.

Findings To Date: The IPR Epidemiology Study currently includes 1781 individuals (1179 cases, 602 siblings; from 1010 households). Many households include a sibling (n=390, 39%) and some include multiple cases (n=205, 20%). Mean enrolment age was 11.3±4.3 years for cases and 10.1±5.3 for siblings. Leading PANS-like features include anxiety (94%), emotional lability (92%) and obsessions (90%). Onsets were sudden and dramatic (27%), gradual with a subsequent sudden and dramatic episode (68%) or a gradual progression (5%). The mean age at early signs/symptom onset was 4 years and 7 years at sudden and dramatic increases, respectively. Infection/illness was the most common suspected symptom trigger (84%). Nearly all cases had been treated with antibiotics (88%) and/or non-steroidal anti-inflammatory drugs (79%). Parents reported immune-related conditions in cases (18%) and their nuclear, biological family (48%; 39% in biological mothers).

Future Plans: Future plans include increasing sample size, collecting longitudinal survey data, recruiting appropriate study controls and expanding the scope of the database, prioritising medical record data integration and creating a linked biorepository. Secondary data analyses will prioritise identifying subgroups by phenotypic traits, maternal health and disease characteristics.

Citing Articles

Developmental Impacts of PANS/PANDAS and Inadequate Support for Children and Families.

LaRusso M, Abadia-Barrero C Child Psychiatry Hum Dev. 2024; .

PMID: 38874750 DOI: 10.1007/s10578-024-01723-0.

References

Mataix-Cols D, Frans E, Perez-Vigil A, Kuja-Halkola R, Gromark C, Isomura K . A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette's/chronic tic disorders. Mol Psychiatry. 2017; 23(7):1652-1658. PMC: 5951741. DOI: 10.1038/mp.2017.215. View

Swedo S, Leonard H, Mittleman B, Allen A, Rapoport J, Dow S . Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997; 154(1):110-2. DOI: 10.1176/ajp.154.1.110. View

Gromark C, Harris R, Wickstrom R, Horne A, Silverberg-Morse M, Serlachius E . Establishing a Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic: Baseline Clinical Features of the Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort at Karolinska Institutet. J Child Adolesc Psychopharmacol. 2019; 29(8):625-633. PMC: 6786340. DOI: 10.1089/cap.2018.0127. View

Chiarello F, Spitoni S, Hollander E, Cerinic M, Pallanti S . An expert opinion on PANDAS/PANS: highlights and controversies. Int J Psychiatry Clin Pract. 2017; 21(2):91-98. DOI: 10.1080/13651501.2017.1285941. View

Trifiletti R, Lachman H, Manusama O, Zheng D, Spalice A, Chiurazzi P . Identification of ultra-rare genetic variants in pediatric acute onset neuropsychiatric syndrome (PANS) by exome and whole genome sequencing. Sci Rep. 2022; 12(1):11106. PMC: 9246359. DOI: 10.1038/s41598-022-15279-3. View

Johnson M, Fernell E, Preda I, Wallin L, Fasth A, Gillberg C . Paediatric acute-onset neuropsychiatric syndrome in children and adolescents: an observational cohort study. Lancet Child Adolesc Health. 2019; 3(3):175-180. DOI: 10.1016/S2352-4642(18)30404-8. View

Chan A, Phu T, Farhadian B, Willett T, Thienemann M, Frankovich J . Familial Clustering of Immune-Mediated Diseases in Children with Abrupt-Onset Obsessive Compulsive Disorder. J Child Adolesc Psychopharmacol. 2020; 30(5):345-346. DOI: 10.1089/cap.2019.0167. View

Murphy T, Gerardi D, Leckman J . Pediatric acute-onset neuropsychiatric syndrome. Psychiatr Clin North Am. 2014; 37(3):353-74. DOI: 10.1016/j.psc.2014.06.001. View

Swedo S, Frankovich J, Murphy T . Overview of Treatment of Pediatric Acute-Onset Neuropsychiatric Syndrome. J Child Adolesc Psychopharmacol. 2017; 27(7):562-565. PMC: 5610386. DOI: 10.1089/cap.2017.0042. View

10.

Frankovich J, Thienemann M, Pearlstein J, Crable A, Brown K, Chang K . Multidisciplinary clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients. J Child Adolesc Psychopharmacol. 2015; 25(1):38-47. PMC: 4340335. DOI: 10.1089/cap.2014.0081. View

11.

Calaprice D, Tona J, Parker-Athill E, Murphy T . A Survey of Pediatric Acute-Onset Neuropsychiatric Syndrome Characteristics and Course. J Child Adolesc Psychopharmacol. 2017; 27(7):607-618. DOI: 10.1089/cap.2016.0105. View

12.

Murphy T, Patel P, McGuire J, Kennel A, Mutch P, Parker-Athill E . Characterization of the pediatric acute-onset neuropsychiatric syndrome phenotype. J Child Adolesc Psychopharmacol. 2014; 25(1):14-25. PMC: 4340632. DOI: 10.1089/cap.2014.0062. View

13.

Lewin A, Storch E, Murphy T . Pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in identical siblings. J Child Adolesc Psychopharmacol. 2011; 21(2):177-82. DOI: 10.1089/cap.2010.0085. View

14.

Prato A, Gulisano M, Scerbo M, Barone R, Vicario C, Rizzo R . Diagnostic Approach to Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Narrative Review of Literature Data. Front Pediatr. 2021; 9:746639. PMC: 8580040. DOI: 10.3389/fped.2021.746639. View

15.

Gromark C, Hesselmark E, Djupedal I, Silverberg M, Horne A, Harris R . A Two-to-Five Year Follow-Up of a Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort. Child Psychiatry Hum Dev. 2021; 53(2):354-364. PMC: 7870456. DOI: 10.1007/s10578-021-01135-4. View

16.

Chang K, Frankovich J, Cooperstock M, Cunningham M, Latimer M, Murphy T . Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol. 2014; 25(1):3-13. PMC: 4340805. DOI: 10.1089/cap.2014.0084. View

17.

Frankovich J, Thienemann M, Rana S, Chang K . Five youth with pediatric acute-onset neuropsychiatric syndrome of differing etiologies. J Child Adolesc Psychopharmacol. 2015; 25(1):31-7. PMC: 4442568. DOI: 10.1089/cap.2014.0056. View

18.

Perez-Vigil A, Fernandez de la Cruz L, Brander G, Isomura K, Gromark C, Mataix-Cols D . The link between autoimmune diseases and obsessive-compulsive and tic disorders: A systematic review. Neurosci Biobehav Rev. 2016; 71:542-562. DOI: 10.1016/j.neubiorev.2016.09.025. View

19.

Hedderly T, Malik O . Childhood Acute Neuropsychiatric Syndromes…furthering the discussion PANS and PANDAS. Eur J Paediatr Neurol. 2018; 22(2):223-224. DOI: 10.1016/j.ejpn.2018.01.022. View

20.

Swedo S, Schrag A, Gilbert R, Giovannoni G, Robertson M, Metcalfe C . Streptococcal infection, Tourette syndrome, and OCD: is there a connection? PANDAS: horse or zebra?. Neurology. 2010; 74(17):1397-8. DOI: 10.1212/WNL.0b013e3181d8a638. View